BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tang D, Luo Y, Jiang Y, Hu P, Peng H, Wu S, Zhang G, Wang Y. LncRNA KCNQ1OT1 activated by c-Myc promotes cell proliferation via interacting with FUS to stabilize MAP3K1 in acute promyelocytic leukemia. Cell Death Dis 2021;12:795. [PMID: 34404765 DOI: 10.1038/s41419-021-04080-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu J, Jiang M, Guan J, Wang Y, Yu W, Hu Y, Zhang X, Yang J. LncRNA KCNQ1OT1 enhances the radioresistance of lung squamous cell carcinoma by targeting the miR-491-5p/TPX2-RNF2 axis. J Thorac Dis 2022;14:4081-95. [PMID: 36389338 DOI: 10.21037/jtd-22-1261] [Reference Citation Analysis]
2 Zhu ZG, Liao GQ, Zhang JX, He CJ, Ni ZC. circVMA21 combining with TAF15 stabilizes SOCS3 mRNA to relieve septic lung injury through regulating NF-κB activation. Mol Immunol 2022;151:183-92. [PMID: 36162226 DOI: 10.1016/j.molimm.2022.07.004] [Reference Citation Analysis]
3 Gao Z, Xu J, Fan Y, Qi Y, Wang S, Zhao S, Guo X, Xue H, Deng L, Zhao R, Sun C, Zhang P, Li G. PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition. J Exp Clin Cancer Res 2022;41:223. [PMID: 35836243 DOI: 10.1186/s13046-022-02431-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Han J, Wang Y, Yang R, Xu Y, Li F, Jia Y. LncRNA FAM225A activates the cGAS-STING signaling pathway by combining FUS to promote CENP-N expression and regulates the progression of nasopharyngeal carcinoma. Pathology - Research and Practice 2022;236:154005. [DOI: 10.1016/j.prp.2022.154005] [Reference Citation Analysis]
5 Shaath H, Vishnubalaji R, Elango R, Kardousha A, Islam Z, Qureshi R, Alam T, Kolatkar PR, Alajez NM. Long Non-Coding RNA and RNA-Binding Protein Interactions in Cancer: Experimental and Machine Learning Approaches. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.05.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]